Contact the Editorial Desk

Editorial correspondence

LKN Peptides welcomes correspondence about the research record covered on this desk: a citation quoted inaccurately, a newly published study on CJC-1295, ipamorelin, or MOTS-c, an updated regulatory or anti-doping status, or a peer-reviewed source that belongs on the references page but is missing from it. This is the most useful class of message this desk receives, and each is read carefully before any change is made.

The most actionable submissions name the specific page, the exact passage in question, and a supporting source — a DOI or PubMed identifier where one exists — so the proposed correction can be checked against its source before anything is changed.

Editorial mailbox: editors@lknpeptides.com

What this desk cannot do

A few categories of message fall outside what this site can usefully answer. LKN Peptides is a literature digest, not a clinical service or a peptide vendor, so it cannot advise on human use of any compound discussed here, recommend or evaluate a dose or schedule for any individual, help locate a supplier, or comment on a specific person's situation. It also cannot advise athletes navigating anti-doping rules, beyond stating the prohibited-substance status already described on each compound page.

None of the compounds on this site is a prescription medicine, and none is legally available for human use outside a research or laboratory context. Readers with a health question should consult a licensed clinician. Responses to editorial correspondence are not guaranteed and the mailbox is checked intermittently.